ArticleCancer medicine2024

Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes.

Lan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.